Robert Lutz
Consulente / Consigliere presso ShangPharma Innovation, Inc.
Posizioni attive di Robert Lutz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ShangPharma Innovation, Inc.
 ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Consulente / Consigliere | - | - |
Storia della carriera di Robert Lutz
Precedenti posizioni note di Robert Lutz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IMMUNOGEN, INC. | Corporate Officer/Principal | 01/01/1992 | 01/04/2015 |
Formazione di Robert Lutz
| University of New Hampshire | Undergraduate Degree |
| Brandeis University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Corporate Officer/Principal | 1 |
| Consultant / Advisor | 1 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Finance |
- Borsa valori
- Insiders
- Robert Lutz
- Esperienza